Laviat 10mg Capsule: Advanced Immunomodulatory Therapy for Oncology Care
Are you looking for a trusted Laviat 10mg Capsule exporter from India? Ernest Impex, a core division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier of specialized oncology medications. We provide high-integrity pharmaceutical distribution and secure cold-chain logistics to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica).
Extensive Product Profile: Understanding Laviat 10mg
Extensive Product Profile: Understanding Laviat 10mg
Laviat 10mg Capsule, manufactured by Zydus Cadila, contains the active ingredient Lenalidomide. This 10mg strength is a critical therapeutic dose used in both the treatment and maintenance phases for patients with specific blood and lymph node cancers. As an immunomodulatory agent, it offers a multi-targeted approach to suppressing malignant cell growth and enhancing the body's natural defenses.
1. Clinical Indications & Primary Usage
Multiple Myeloma (MM): Often used in combination with dexamethasone for patients who have received at least one prior therapy or as maintenance therapy after a stem cell transplant.
- Myelodysplastic Syndromes (MDS): Specifically for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.
- Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after two prior therapies.
- Follicular Lymphoma (FL): Used in combination with a rituximab product for previously treated patients
2. Mechanism of Action: The Triple-Action Anti-Tumor Response
Lenalidomide, the active molecule in Laviat, works through a sophisticated multi-pathway mechanism:
Patients undergoing treatment with Laviat 10mg must be closely monitored for adverse reactions, including:
- Immune System Activation: It stimulates the proliferation and activation of T-cells and Natural Killer (NK) cells, empowering the body to identify and destroy cancer cells.
- Anti-Angiogenesis: It inhibits the formation of new blood vessels that tumors require to receive nutrients and oxygen, effectively "starving" the cancer.
- Direct Cytotoxicity: It triggers apoptosis (programmed cell death) in malignant cells by interfering with internal signaling and the CRL4CRBN E3 ubiquitin ligase complex.
- Bone Marrow Modulation: It alters the production of cytokines (chemical messengers) in the bone marrow that otherwise support cancer cell survival.
3. Administration and Dosing
- Consistency: Take the capsule at the same time every day, with or without food.
- Method: Swallow the capsule whole with water.
Do not break, chew, or open the capsule, as the powder inside is hazardous. - Cycle: Treatment is typically administered in cycles (e.g., 21 days on, 7 days off).
4. Potential Side Effects of Laviat 10mg
- Hematological Effects: Significant reduction in white blood cells (neutropenia) and platelets (thrombocytopenia), which increases the risk of infection and bleeding.
- Systemic Symptoms: Fatigue, fever, muscle cramps, back pain, and weakness.
- Gastrointestinal: Nausea, diarrhea, constipation, and abdominal discomfort.
- Serious Risks: Increased risk of blood clots (DVT/Pulmonary Embolism) and potential for severe, life-threatening birth defects (teratogenicity).
- Dermatological: Skin rashes or itching.
5. Storage, Handling, and Stability Protocols
- Temperature: Store below 30Β°C in a cool, dry place.
- Moisture Protection: Keep capsules in their original blister packaging until the time of administration.
- Safety Isolation: Store in a secure location out of reach of children and pets.
- Disposal: Unused medication should be returned to a pharmacy or healthcare provider for hazardous waste disposal.
PRESCRIPTION MEDICINE IS YES
Disclaimer: The information provided is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any medical or treatment decisions.
π Contact Ernest Impex β Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
π Websites:
π§ Email:
| www.ernestimpex.com www.ernestvision.com | www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com exports@ernestpharmaceuticals.com
π¦ Business Type: Exporter | Bulk Supplier | Distributor
π² WhatsApp: +91 93599 02383
π² WhatsApp Link:https://wa.me/919359902383